MedPath

New Clinical Applications for Internet-based Cognitive Behavior Therapy for Insomnia and Depression

Not Applicable
Completed
Conditions
Major Depression
Insomnia
Minor Depression
Interventions
Behavioral: Therapist guided Internet-CBT for insomnia and depression
Behavioral: Therapist Guided Internet-CBT for depression plus insomnia placebo
Behavioral: Therapist guided Internet-CBT for insomnia w. extra support
Behavioral: Therapist guided Internet-CBT for insomnia
Registration Number
NCT01663844
Lead Sponsor
Karolinska Institutet
Brief Summary

This study includes two sub-trials. Both are included in this singe registration since they have parallel inclusion of participants and have been approved by the Swedish ethics board together in one application.

Trial 1 includes patients with both insomnia and major or minor depression. Participants are randomized to either a combined therapist guided Internet-CBT for insomnia and depression, or to Internet-CBT for depression with an addition of a placebo intervention for insomnia. The primary purpose is to evaluate changes in insomnia and depression severity for the combination treatment compared to the depression treatment, after treatment and at 6 and 36 months follow up. A secondary purpose is to evaluate cognitive functioning before and after treatment, as well as cost effectiveness. Recruitment is done in the Stockholm County through mass media and the Internet psychiatry clinic's regular patient recruitment.

Trial 2 includes patients with insomnia who do not meet criteria for major or minor depression. All participants start therapist guided Internet-CBT for insomnia. After 4 weeks patients that are judged to be at risk of treatment failure are randomized to either continued treatment or treatment with added support intended to enhance outcome. The primary purpose is to evaluate change in insomnia severity for participants who get added support, compared to continued treatment with regular support level. A secondary purpose is to evaluate cognitive functioning before and after treatment, as well as cost effectiveness. Recruitment is done in the Stockholm County through mass media and the Internet psychiatry clinic's regular patient recruitment.

NOTE:

The first participants in trial 1 will be regarded as pilots, due to problems with the experimental treatment: technical issues as well as problems with the design of treatment modules. These problems were corrected when discovered. 12 participants in the experimental arm were affected by these errors. The pilot participants will not be included in the main analyses of data. This was decided upon on 31st of October 2014.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
440
Inclusion Criteria
  • Clinical level of Insomnia (more than 10 on ISI)
  • Meets criteria for Insomnia according to DSM-IV-TR
  • Enough language skills
  • Only Trial 1: Meets criteria for Major or Minor Depressive Disorder according to DSM-IV-TR (for minor depression a MADRS-S-level of >19 is required).
Exclusion Criteria
  • Sleep disorders requiring other treatment
  • Alcohol/drugs abuse
  • Started to use or changed the dose of antidepressant drug during the last 2 months
  • Somatic or psychiatric conditions requiring acute care
  • Working night shifts
  • Only Trial 2: Meets criteria for Major or Minor Depressive Disorder according to DSM-IV-TR (for minor depression a MADRS-S-level of >19 is required for exclusion).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
(Study 1) ICBT for insomnia and depressionTherapist guided Internet-CBT for insomnia and depression-
(Study 1) ICBT for depr. plus placebo insomnia interventionTherapist Guided Internet-CBT for depression plus insomnia placebo-
(Study 2) ICBT for insomnia with added supportTherapist guided Internet-CBT for insomnia w. extra support-
(Study 2) ICBT for insomnia with regular level of supportTherapist guided Internet-CBT for insomnia-
Primary Outcome Measures
NameTimeMethod
Change (from baseline) in Insomnia Severity Index (ISI)0, 6 and 36 months after treatment

7-item, self-rated questionnaire measuring change in insomnia severity. Bastien, C. H., Vallières, A., \& Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297-307.

Change (from baseline) in Montgomery Asberg Depression Rating Scale, MADRS-S0, 6 and 36 months after treatment

Defined as secondary outcome measure in Trial 2. The use of two primary outcomes in trial 1 is motivated since participants have both diagnoses and the purpose is to look at effects on both insomnia and depression.

The MADRS-S is a 9-item self-rated measure of change in depression severity. It also screens for suicidality.

Mattila-Evenden, M., Svanborg, P., Gustavsson, P., \& Åsberg, M. (1996). Determinants of self-rating and expert rating concordance in psychiatric out-patients, using the affective subscales of CPRS. Acta Psychiatr Scand, 94, 386-396.

Secondary Outcome Measures
NameTimeMethod
Change (from baseline) in Sleep DiaryDirectly after treatment

One week of self-ratings on a number of sleep parameters, resulting in measures of sleep latency, total sleep time, sleep efficacy, number of nighttime awakenings, subjective sleep quality and daytime functioning.

Change (from baseline) in Cognitive functioningDirectly at post-treatment

Computer based testing of executive functions, concentration, speed and memory.

Change (from baseline) in Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P)0, 6 and 36 months after treatment

Health economic questionnaire evaluation cost for health care, absence of work capacity and related costs.

Hakkaart-Van Roijen, L.,Van Straten, A., \& Donker, M. (2002). Manual: Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness. Rotterdam: Erasmus University

Change (from baseline) in Sheehan Disability Scale0, 6 and 36 months after treatment

Measures daily life functioning. Sheehan, D. V. (1983). The Anxiety disease. Scribner: New York

Changes (from baseline) in Actigraph dataDirectly post treatment

An actigraph is placed on the participant's arm for one week. They measure participants' activity in the form of movements. It will be used for acquiring sleep data and calculate sleep latency, total sleep time, sleep efficacy, number of nighttime awakenings and daytime activity.

Change (from baseline) in EuroQuol. EQ-5D0, 6 and 36 months after treatment

General quality of life measure to complement the TIC-P in health economic analysis.

Hinz, A., Klaiberg, A., Brahler, E., \& Konig, H.H. (2006). The Quality of Life Questionnaire EQ-5D: modelling and norm values for the general population. Psychother.Psychosom.Med.Psychol., 56, 42-48.

Change (from baseline) in Clinical Outcome in Routine Evaluation - 10, CORE-OM0, 6 and 36 months after treatment

Measures psychological health in general. Evans, C., Connell, J., Barkham, M., Margison, F., McGrath, G., Mellor-Clark, J. \& Audin, K. (2002). Towards a standardised brief outcome measure: psychometric properties and utility of the CORE-OM. The British journal of psychiatry : the journal of mental science 180, 51-60.

Trial Locations

Locations (1)

Internetpsykiatrienheten (Internet Psychiatry Clinic) Psykiatri Sydväst, SLSO

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath